Back
Day Range
$4.94
$5.19
52-Week Range
$1.89
$7.01
Volume
1,952,867
50D / 200D Avg
$5.61
/
$4.23
Prev Close
$4.96
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.8 | 0.4 |
| P/B | 5.1 | 2.9 |
| ROE % | -63.5 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.2 | 0.2 |
Key Takeaways
Debt/Equity of 0.15 — conservative balance sheet
Negative free cash flow of -101.06M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-63.45%
ROIC-39.76%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.15
Current Ratio11.85
Interest Coverage0.00
Valuation
P/E Ratio
-8.75
P/B Ratio5.12
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -118.84M |
| ROE | -63.45% | ROA | -46.89% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -101.06M |
| ROIC | -39.76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.15 | Current Ratio | 11.85 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -8.75 | P/B Ratio | 5.12 |
| P/S Ratio | N/A | PEG Ratio | -1.08 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.04B | Enterprise Value | 1.04B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -118.84M | -95.88M | -54.70M | -38.15M | -43.01M |
| EPS (Diluted) | -0.53 | -0.48 | -0.33 | -0.25 | -0.32 |
| Gross Profit | -245,000.0 | -78.03M | -44.26M | -27.88M | -28.99M |
| Operating Income | -123.55M | -103.20M | -60.01M | -38.84M | -41.48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 253.44M | 212.88M | 177.56M | 139.78M | 176.60M |
| Total Liabilities | 50.30M | 41.43M | 37.19M | 32.00M | 32.10M |
| Shareholders' Equity | 203.13M | 171.45M | 140.37M | 107.78M | 144.50M |
| Total Debt | 29.91M | 26.74M | 26.49M | 26.14M | 25.79M |
| Cash & Equivalents | 33.18M | 15.13M | 26.59M | 52.10M | 34.01M |
| Current Assets | 241.62M | 202.14M | 165.95M | 128.95M | 165.00M |
| Current Liabilities | 20.40M | 14.72M | 10.60M | 5.87M | 14.66M |